T1	Participants 31 57	non-small cell lung cancer
T2	Participants 278 318	patients with non-small cell lung cancer
T3	Participants 496 583	patients which were treated either by lymph node sampling or systematic lymphadenectomy
T4	Participants 1294 1414	61 patients, pN1 disease in 13 patients and pN2 disease in 20 patients without significant differences between LA and LS
T5	Participants 1662 1711	the subset of patients with nodal micrometastases
T6	Participants 2075 2136	patients without an early locoregional spread of cancer cells
